| __timestamp | Rhythm Pharmaceuticals, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1213000 | 5496000 |
| Thursday, January 1, 2015 | 3425000 | 9786000 |
| Friday, January 1, 2016 | 6311000 | 6792000 |
| Sunday, January 1, 2017 | 9518000 | 7313000 |
| Monday, January 1, 2018 | 28080000 | 8382000 |
| Tuesday, January 1, 2019 | 36550000 | 10803000 |
| Wednesday, January 1, 2020 | 46125000 | 12944000 |
| Friday, January 1, 2021 | 68486000 | 21967000 |
| Saturday, January 1, 2022 | 92032000 | 32810000 |
| Sunday, January 1, 2023 | 117532000 | 46542000 |
Igniting the spark of knowledge
In the competitive landscape of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustainable growth. Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc. have shown contrasting trajectories in their SG&A efficiency from 2014 to 2023. Rhythm Pharmaceuticals has seen a staggering increase of over 9,500% in SG&A expenses, reflecting its aggressive expansion and investment in market penetration. In contrast, Xenon Pharmaceuticals has maintained a more conservative growth of approximately 750%, indicating a strategic focus on cost management while scaling operations. This divergence highlights the varied strategies companies employ to balance growth and efficiency. As the industry evolves, understanding these financial dynamics becomes essential for investors and stakeholders aiming to gauge a company's operational health and strategic direction.
Operational Costs Compared: SG&A Analysis of AstraZeneca PLC and Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Sanofi and Rhythm Pharmaceuticals, Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Rhythm Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.